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els of B-Type natriuretic peptide despite significantly increased LV mass and volumes, 
even in patients with symptoms. Therefore, BNP may not be a useful marker in the man- 
agement and evaluation of patients with chronic MR 
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841-I The Effective Regurgitant Orifice Area Is Predictive of 
Survival in Patients With Organic Mitral Regurgitation 
Maurice L. Enriauez-Sarano, A. Jamil Tajrk, David Messika-Zeitoun, Jean-Francois 
Avierinos, Michael Bellamy, Christophe Triboullloy, Mayo Clinic, Rochester, MN 
Background: Quantitation of mitral regurgitation (MR) is possible using Doppler- 
Echocardiography and allows measurement of the Effective Regurgitant orifice (ERO) 
area and of the Regurgitant volume (RVol). However, the implications of these measure- 
ments regarding survival after diagnosis are unknown because no long-term study out- 
come study has yet been conducted. 
Methods: We prospectively enrolled 456 patients with MR due to organic mitral lesions 
(mitral prolapse in 360 or 79%) in whom quantitatlon of MR was obtained at baseline by 
at least 2 independent methods. The end-points analyzed were survival under conserva- 
tive management and the combined end-point of death or mitral surgery. 
Results: At diagnosis, age was 64+14 years and 61% were male, ERO was 41i26 mm2 
(range 2 to 180 mm2) and RVol was 65+40 ml/beat (range 3 to 227). The left ventnculat 
end-diastolic volume was enlarged at 107+26 mUm2 and the ejection fraction was nor- 
mal at 69+9%. The 5.year rates of mortality under conservative management and of sur- 
gery or death were 24+3% and 66+3%. Both ERO and RVol were unwariately predictive 
of these end-points (PcO.001) but in multivariate analysis adjusting for age, sex, func- 
tional class and ejection fraction, only ERO was predictive of suwival (RR 1.22 [1.06- 
1.381 par 10 mm2 increase, P=O.O05). ERO was also independently predictive of death 
or mitral surgery (RR 1.41 [1.29-l ,521 per IO mm2 increase, P-zO.001). 5 years after diag- 
nosis, for patients with ER0<20, 20-30 and X30 mm3. mortality under conservative man- 
agement was 9+3%. 31 +lO% and 49*6%, respectively and death or mitral surgery 
(excluding patients operated within 3 months of diagnosis) was 14*4%, 55*9% and 
63+4%. respectively (both P<O.OOl). 
Conclusion: The present study demonstrates for the first time in patients with organic 
MR. l-the strong outcome implications of quantitative measures of degree of MR, P-the 
preeminent Independent prognostic value for surwal of ERO area. which 3.allows to 
stratify patients into groups at low-, medium- and high-risk. Hence. measurement of ERO 
area of MR is an essential tool in management of patients with orgamc MR. 
6145 a.m. 
841-2 Brain Natriuretic Peptide Predicts Severity of Aortic 
Stenosis 
Johann Auer, Thomas Weber, Robert Berent, Elisabeth Lassnig. Josef Seier, Bernd 
Eber, General Hospital Wels, Wels, Austria 
Background: Bratn natriuretic peptide (BNP) and atrial natriuretic peptide (ANP) consti- 
tute a cardiac hormone system mediating natriuresis, diuresis, and vasodilation. 
Whereas ANP is secreted mainly from cardiac atria, BNP is produced to a larger extent in 
ventricles and has been shown to correlate with end-systolic wall stress in patients with 
aorilc stenosis (AS). Echocardiography with doppler examination of the aortic valve pro- 
vides a vary accurate assessment of the trans.valvular aortic pressure gradient (TVPG) 
and is used to monitor progression of AS. This study evaluated circulating BNP as a 
marker of left ventricular hyperirophy and atrial pressure increase in patients with AS. 
Patients and Methods: We westigated the serum concentrations of BNP by radioimmu- 
noassay in 69 AS patients (35 males, mean age 70,9 years; range 37-90; mean TVPG 
determlned by echocardlography 45,2 mmHg (+I- 20.6). calculated mean aortic valve 
area (AVA) (assessed invasively) 0,65 cm2 (+/- 0.3). TVPG were correlated to the AVA 
(r=O.54, P=O.OOl). Results are expressed as mean (+/- standard deviation), correlations 
were tested by Spearman-rang test and comparisons between group were tested by the 
Mann-Whitney test. 
Results: BNP levels were slgnlficantly higher I” AS patients with AVA less than 1 cm2 
(2558,5 pg/ml; +I- 2555,6) when compared with the patients with AVA more than 1 cm2 
(1567,4 pglml (+/- 2447,9) P=O,O49). Moreover, BNP levels were increased in AS 
patients with TVPG of 50 (60.5 +/- 10,3) mmHg or more (4351,4 pgiml; +/- 4699,5) in 
comparison to patients with TVPG less than 50 (29,9 +/- 16,6) mmHg (1373,6 pg/ml: +/- 
2176.8, P=O,O4). BNP levels ware correlated to the TVPG and AVA (w0.43 and wO.52, 
P<O.OOl), respectively. 
Conclusion: These results suggest BNP levels rncrease I” relation to the NPG and AVA. 
BNP measurement could potentially be used to monitor progression of disease non-inva- 
sively. This marker may also be useful to identify the optimum time for surgery in AS. 
JACC March 19,2003 
9:00 a.m. 
841-3 Mitral Annular Calcification, Aortic Sclerosis, and 
Incident Stroke in American Indians Free of Clinical 
Cardiovascular Disease 
Jorae R. Kizer, David 0. Wiebers, Jack P. Whisnant, James M. Galloway, Thomas K. 
Welty, Elisa T. Lee, Lyle Best, Mary J. Roman. Richard B. Devereux, Weill Medical 
College of Cornell University, New York, NY, Mayo Clinic, Rochester, MN 
While mitral annular calcification (MAC) 8 aortic sElerosis have been reported to be risk 
factors for cerebrovascular events, their relative prognostic significance Independent of 
other echo predictors is uncertain. We investigated the predictive value of MAC & aortic 
sclerosis for lncldent stroke while accounting for other proven echo predictors. Our 
cohort comprised American Indians in the Strong Heart Study having echo in 1993.95. 
Exclusion criteria: coronaty/valvular disease (aortic stenosis); prior stroke; atrlal flbrilla- 
tion; ejection fraction -< 35%; segmental wall motion abnormality. Follow-up was obtained 
through 12/99. N = 2659. Age = 56 y, women = 64%. hypertension = 54%, diabetes = 
47%. cholesterol/HDL = 4.7, body-mass index = 31 kg/m2, smoker = 31%, renal insuff- 
ciency = 2.3%, MAC = lo%, aortic sclerosis = 8% left atrial index = 2.2 cm/m, LV mass 
index = 40 g/m2 7. lncldent strokes = 60. MAC, but not aortic sclerosis, was a significant 
univariable predictor of stroke (Figure). In Cox models adjusting for all above factors, 
MAC emerged as an independent predictor of stroke (RR 2.2, P = 0.026). Aortic sclerosis 
was not predictive whether or not MAC was considered. Our findings demonstrate MAC 
to be a strong predictor of stroke independent of other echo risk factors, & are in line with 
other studies showing that aortic sclerosis is not independently predictive of cerebral 
events. In patients without overt cardiovascular disease, the isolated presence of MAC 
warrants aggressive primary prevention. 
9:15 a.m. 
841-4 Does Aortic Valve Sclerosis Predict Cardiovascular 
Events Independently of Albuminuria in Hypertension? 
A LIFE Study 
Michael H. Olsen Kristian Wachtell, Jonathan N. Bella. Vittorio Palmieri, Eva Gerdts, 
Markku S. Nieminen. Gunnar Smith. Blbrn DahlBf. Hans Ibsen. Richard B. Devereux. , 
Glostrup University Hospital, Copenhagen, Denmark, The Weill Medical College of 
Cornell University, New York, NY 
Background: Aortic valve (AV) sclerosis and albuminuria are strong cardiovascular risk 
factors and they are both thought to be markers of atherosclerosis. In the LIFE study we 
investigated the predictive value of AV sclerosis for the composite endpoint (CEP) of car- 
diovascular death, non-fatal stroke or non-fatal myocardlal Infarctron correcting for urine 
albuminlcreatinine ratio (UACR) and other cardiovascular risk factors. 
Methods: After two weeks of placebo treatment, clinical, laboratory, and echocardio- 
graphic variables were assessed in 960 hypertensive patients from the LIFE Echo sub- 
study, aged 55-60 (mean 66*7) years, with electrocardiographic LV hypertrophy, and 
without known AV stenosis. Morning urine albumin and creatinine were measured, and 
urine albumin-creatinine ratio (UACR) was calculated. Macro- and microalbumlnuria 
were defined as UACRa5 and 3.5cUACR<35, respectively. AV sclerosis was defined as 
valve thickening or calcification. 15 patients with mild AV stenosis were excluded. 
Results: AV sclerosis was found in 366 patients and was associated with higher inci- 
dence of CEP (15.5% vs. 6.3%“). Micro- and macroalbuminuria were found in 143 
(17.1%) and 23 (2.6%) patients, respectively, and both were associated with higher Inci- 
dence of CEP (15% and 22% vs. 9.9%‘). The incidence of CEP increased progressively 
with micro- and macroalbummuria in oatients without AV sclerosis II 1.4% and 15.4% vs. 
8.3%‘) as well as in patients with AV sclerosis (19.2% and 30% vs. 12.7%‘). In Cox 
reoression analvses AV sclerosis was oredlctlve of the CEP [odds ratio IORl = 1.6’) inde- 
pendent of log UACR (I .5’); male gender (2.1”); and history of peripheral vascular dis- 
ease (2.5-I diabetes mellitus (2.3”) or cerebral vascular disease (2.4.‘). P<O.O5. 
JACC March 19,2003 
“P<O.O1. 
Conclusions: AV sclerosis and albuminuria predict cardiovascular morbidity and mortal- 
Ity in hypertensive patients with electrocardiographic LV hypertrophy independently of 
each other and established cardiovascular nsk factors, indicating that they are not Inter- 
changeable markers of the same atherosclerotic process. 
9:30 a.m. 
841-5 Mitral Annular Calcification Association With 
Cardiovascular Events in African Americans: The ARIC 
Cohort 
Doug Harkins, Ewin R. Fo& Herman Taylor, Michael McMullan, Hui Han, Tandaw 
Samdarshi, Robert Garrison, Thomas Skelton, University of Mississippi Medical Center, 
Jackson, MS 
Background: The prevailing opinion in the medical literature is that mitral annular calcifi- 
cation (MAC) represents a manifestation of atherosclerosis and should alert the clinician 
to the possibility of cardiovascular disease. Despite the apparent link between MAC and 
atherosclerosis, there is limited data regarding the correlation between MAC and coro- 
nary (CHD) events in African Americans. The objective of this study is to assess if MAC 
predicts CHD events in the Jackson (completely African American) cohort of the ARIC 
Study. Methods: The study population included 2193 participants undergoing echo 
examinations between 1993 and 1996. Participants diagnosed with heart disease prior to 
visit 3 and participants who did not have adequate visualization of the mitral annulus to 
assess for MAC on 2D imaging were excluded. The primary outcome was incident CHD 
event [defined as hospitalized myocardial infarction (Ml), ECG (silent) MI, fatal coronary 
event or cardiac procedure] in ARIC as observed up to 1999. MAC was considered a 
binary variable (yes/no) and was adjusted for signlflcant confounders including gender, 
age, BMI, hypertension. diabetes, smoking status, renal function based on serum creati- 
nine, and total cholesterol to HDL ratio. Cox proportional hazard model was used for the 
analysis. Results: The prevalence of MAC was 4.6% for women and 5.6% for men. The 
prevalence increased with age. In participants aged 65 years and higher, the prevalence 
of MAC was 7.1% in women and 6.2% in men. During the 5 year follow up, there were 
122 total incident CHD events recorded, 62 of which were hospitalized Ml and fatal CHD 
events. The relatwe risk of hospitalized MI and fatal CHD events was 2.2 (95% Cl, 1.2 to 
4.1) for those with MAC. Aner adjustment, the risk for CHD events among the MAC sub- 
group was 2.4 (95% Cl, 1 .I to 5.0). Broadening the definition of CHD events to include 
procedures and silent MI the unadjusted relative risk was 2.2 (95% Cl,l.2 to 4.1) and 
adjusted relative risk was 2.0(95% Cl,l.O4 to 3.9) Conclusions: Despite the low preva- 
lence of MAC in this relatively young population of middle-aged African Americans, the 
presence of MAC incurs a significant risk for cardiovascular events. 
9:45 a.m. 
841-6 Effect of Pulmonary Artery Systolic Pressure on 
Mortality in Patients With Mitral Regurgitation and 
Normal Systolic Function 
Richard V. Milan!, Carl J. Lavie, Yvonne E. Gilllland, Mark M. Cassidy, Jose Albert0 
Bernal, Mahesh Mulumudi, Ochsner Clinic Foundation, New Orleans. LA 
Background: Severe degrees of mitral regurgitation (MR) are known to exert an unfavor- 
able prognosis. However, little is known regarding prognosis in patients with milder 
degrees of MR, particularly in patients with preserved systolic function. 
Methods: We quantitated MR by routine color flow Doppler echocardiography and evalu- 
ated its independent effect on mortality in 13.466 patients (41% male) with normal sys- 
tolic function (EF >/= 50%) followed for an average of 3.1 years. We then assessed the 
additional independent effect of pulmonary hypertension on prognosis in MR in a subset 
of patients where PAS was obtalned (n=7,776) 
Results: (See table; ‘pcO.0001 compared to none and mild, ~p<O.OOOl compared to all 
other groups, $p<O.O5 compared to none and mild). 
Conclusions: In patients with normal systolic function. a moderate level of MR is assow 
ated with a high mortality when PAS >/= 40 mmHg, similar in magnitude to a severe level 
of MR. In these patients, consideration should be aiven to surgical intervention or other 
measures to reduce PAS pressure 
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1157-21 Survival After Valve Replacement for Aortic 
Regurgitation: Prediction From Noninvasive 
Contractility Measurement and Comparison With 
Census-Expected Survival 
Jeffrev S. Borer, Edmund M. Herrold, Phyllis G. Supine, Clam A. Hochreiter. Richard 8. 
Devereux, Mary J. Roman, Paul D. Kkgfield, 0. Wayne Isom, Karl H. Krieger, Andrew 
Yin, Leonard Heame, N. Philip Ross, Weill Medical College of Cornell University, New 
York, NY 
Background: In asymptomatic pts with aortic regurgitation (AR) who have nl left ventricu- 
lar ejection fraction (LVEF) at rest and have not undergone valve replacement (AVR), we 
showed that contractility (wall-stress[ESS]-adjusted change [A] in LVEF from rest to ever- 
cise [ex]) from combined echo and radlonuclide angiography, is the best objective or clin- 
ical predictor of subsequent development of heart failure, subnl LVEFrest or sudden 
death. 
Methods: To confirm its value, in 71 consecutive pts with AR who underwent AVR. we 
related immediate pre-AVRALVEFAESS, other echo and radionuclide angiographic rest 
and ex variables, and symptoms, to survwal during 12+5 yrs post-AVR, and compared 
survival to that expected from age- and gender-matched U.S. census data. EFrest was nl 
pre-AVR in 4Oi71 pts; 51/71 had pm-op symptoms. Pts were divided into 3 groups 
according to pre-specified contractility cut-points used in our earlier study of non-AVR 
pts. 
Results: ALVEF-AESS predicted survival (p=.Ol); neither symptom status, EFrest, EFex, 
AEF, nor echo LV systolic/diastolic dimensions added significant predictive value. Among 
prespecified terciles. pts with near nl contractility (ALVEF-AESS-11%) had av annual 
death risk (AAR) of 1.7 %/yr. indistinguishable from U.S. census data (NS) but better 
than other terciles (pc.04); pts with ALVEFAESS -12% to -17% (middle tercile) had 
AAR=3.5%/yr (pc.025 vs census); pts with poorest ALVEF-AESS e17%) had 
AAR=7.l%/yr (p-z.005 vs census). 
Conclusions: In parallel with earlier results in non-AVR pts, direct contractility measure- 
ment immediately pre-AVR @LVEF adjusted for AESS from non-invasive measures) 
best predicts post-AVR survival compared with other clinical and objective functional/ 
geometric descriptors. Comparison with U.S. census data suggests that, with current sur- 
gical methods, pts with well-preserved contractility, irrespective of symptoms, survive 
post-AVR as well as non-AR persons; in contrast, poor pre-op contractility compromises 
outcome despite nl LVEFrest and irrespectwe of symptoms. “Prophylactic” AVR in pts 
with nl LVEFrest, no symptoms and poordLVEF-AESS may prevent further contractility 
loss and greater post-AVR risk. 
1157-22 Aortic Regurgitation: Long-Term Survival in Patients 
With Different Degrees of Left Ventricular Function 
Undergoing Surgical Treatment 
Pablo Stutzbach, Stella Yala, Sol Garrido, Jose Abud, Eduardo Dulbecco, Alejandro 
Machain, HBctor Raffaelli, Roberto R. Favaloro, Favaloro Foundation, Buenos Aires, 
Argentina 
Background: Outcomes of surgical treatment for aortic regurgitation have been mostly 
reported during the 1960s. However, surgical techniques and treatment of aortic regurgi- 
tation improved smce then. Therefore, it is necessary to update the information and 
review ten ventricular function parameters in relation to greater mortality rates. Our aim 
was to analyze long-term survival and prognostic variables I” patients undergoing sur- 
gery for aortic regurgitation in the past IO years. 
Methods: From August, 1992 to December, 2001, 450 pattents underwent surgery for 
severe aortic regurgitabon. Seventy-nine (16%) patients were excluded from the study, 
since they presented concomitant valvular heart or coronary diseases. Mean age was 
52*15 years; 74 (20%) were women, 67 (18%) were asymptomatic, 28 (7.5%) had his- 
tory of acute pulmonary edema (APE), and 166 (50.6%) had ~40% left ventricular ejec- 
tion fraction (LVEF). Mean left ventricular systolic diameter (LVSD) was 49+5mm. Kaplan 
Mew curves were used for survival analysis. Log-rank test was used for comparison of 
survival rates. Cox test was used for multivarlate analysis. 
Results: Total hospital mortality was 4% (15/371). Female sex (Pc.02) and LVEF ~40% 
(P=.OO2) were the variables associated to greater hospital mortality. Survival at 5 and 6 
years was 97.4*0.9% and 83.7t2.9% respectwely for the total population. Survival anal- 
ysis showed significant differences when comparing ~40% versus 40% LVEF (95% Cl, 
67.96% versus 78% Cl, 61.73%, P=.OO4) and Z3Omm versus c60mm LVSD (89% Cl, 
92.84% versus 70% Cl, 75.67%, k.006). Multivariate analysis of the variables associ- 
ated to mortality showed: age (P=.OO4). ~40% LVEF (F10.006). 260”” LVSD (f=.O74), 
and APE (E.01). 
Conclusion: Patients with isolated aortic regurgitation have low hospital mortality and 
excellent long-time survival despite LVEF impairment. 
